Akebia Therapeutics' earnings outlook improved and was noted for outperforming peers, while ResMed was also reported for outperforming the medical sector.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Akebia Therapeutics' earnings outlook improved and was noted for outperforming peers, while ResMed was also reported for outperforming the medical sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Akebia Therapeutics (United States)
company in Cambridge, United States
Nothing else this week.
-
Resmed
manufacturer of CPAP masks, machines and products that diagnose, treat or help manage respiratory conditions
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksIs Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year? For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming t